Jardiance is also authorised to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. According to the FDA, heart disease impacts more than ...
The FDA has granted a speedy review of Eli Lilly and Boehringer Ingelheim’s Jardiance for a potential ... Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in ...